Press Releases on November 9, 2020 - EIN Presswire - Press Release Distribution Service

Published on November 9, 2020 - 12:00 GMT

Intercept Pharmaceuticals Reports Third Quarter 2020 Financial Results, Announces Updates to Financial Guidance and Provides ...

Worldwide Ocaliva net sales of $79.5 million in the third quarter 2020, representing 29% growth over the prior year quarter Intercept updates 2020 Ocaliva Net Sales Guidance to narrow the range to $310 million to $320 million Intercept updates 2020 non- …

Distribution channels:

Published on November 9, 2020 - 12:00 GMT

MTBC Reports Third Quarter 2020 Results with Record Revenue and Adjusted EBITDA

Reaffirms Full-Year Outlook SOMERSET, N.J., Nov. 09, 2020 (GLOBE NEWSWIRE) -- MTBC, Inc. (the “Company” or “MTBC”) (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services, today announced …

Distribution channels: IT Industry ...

Published on November 9, 2020 - 12:00 GMT

Neos Therapeutics Reports Third Quarter 2020 Financial Results

DALLAS and FORT WORTH, Texas, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today reported financial results for the …

Distribution channels:

Published on November 9, 2020 - 12:00 GMT

INmune Bio, Inc. Announces First Patient Dosed in Phase 2 Trial of Quellor™ for Pulmonary Complications in COVID-19 Patients

LA JOLLA, Calif, Nov. 09, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the, “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, announced today that …

Distribution channels: Media, Advertising & PR, Technology

Published on November 9, 2020 - 12:00 GMT

Orchard Therapeutics to Present at Barclays Gene Editing & Gene Therapy Summit

BOSTON and LONDON, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that the company is scheduled to present at the Barclays Gene Editing & Gene Therapy Summit on November 16, 2020 at …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on November 9, 2020 - 12:00 GMT

Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent ...

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Monday, November 16th, 2020 at 4:30pm Eastern Time to discuss corporate updates and financial …

Distribution channels:

Published on November 9, 2020 - 12:00 GMT

Caldas Gold Extends Main Zone More Than 300 Meters Along Strike; Announces Record Intercept of 5.73 g/t Au Over 63.20 Meters in ...

TORONTO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Caldas Gold Corp. (TSX-V: CGC; OTCQX: ALLXF) is pleased to announce additional higher-grade gold intercepts over broad widths from the ongoing 2020-2021 drilling program at its Marmato Project in Caldas, Colombia. …

Distribution channels: Business & Economy, Media, Advertising & PR ...

Published on November 9, 2020 - 12:00 GMT

Avadel Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Update on FT218 Development Program

NDA for once-nightly FT218 is on track for FDA submission by end of December 2020 New market assessment data identifies a significant potential market expansion opportunity for once-nightly FT218 beyond existing twice-nightly sodium oxybate patients …

Distribution channels:

Published on November 9, 2020 - 12:00 GMT

Zentalis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Update

Announced topline data from the Phase 1 monotherapy dose escalation trial of ZN-c5, its investigational oral SERD, in patients with ER+/HER2- advanced breast cancer; Phase 2 trial expected to initiate in H1 2021 Entered into a clinical collaboration with …

Distribution channels:

Published on November 9, 2020 - 12:00 GMT

Calithera Biosciences Presents New Preclinical Data for CB-668 at Society for Immunotherapy of Cancer (SITC) 2020 Annual Meeting

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life- …

Distribution channels: Culture, Society & Lifestyle, Media, Advertising & PR ...

Published on November 9, 2020 - 12:00 GMT

Nanox Announces Third Quarter 2020 Results and Provides Business Update

On track to obtain 510(k) clearance for multi-source Nanox.ARC by mid-year 2021 Signs agreement with SPI Medical for deployment of 630 Nanox.ARC units across Mexico and Guatemala; brings total contracted deployments to 5,150 across 13 countries Ended Q3 …

Distribution channels:

Published on November 9, 2020 - 12:00 GMT

Plug Power Announces 2020 Third Quarter Results

LATHAM, N.Y., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ:PLUG), a leading provider of hydrogen engines and fueling solutions enabling e-mobility, has announced today its 2020 third quarter results. The quarterly shareholder letter has been …

Distribution channels: Culture, Society & Lifestyle, Electronics Industry ...

Published on November 9, 2020 - 12:00 GMT

New study to determine how many Canadians have been infected with SARS-CoV-2

MONTREAL, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Canada’s COVID-19 Immunity Task Force (CITF) is supporting a new study to identify how many Canadians have been previously infected with SARS-CoV-2, the virus that causes COVID-19. The project, conducted by …

Distribution channels:

Published on November 9, 2020 - 12:00 GMT

Trevena, Inc. to Participate in the Following November Virtual Investor Conferences

-- Guggenheim Healthcare Talks - 2nd Annual Neuro/Immunology Day Conference November 16th Stifel Virtual Healthcare Conference November 18th -- CHESTERBROOK, Pa., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company …

Distribution channels:

Published on November 9, 2020 - 12:00 GMT

Axovant Gene Therapies Announces FDA Clearance of IND for AXO-AAV-GM2 Gene Therapy in Tay-Sachs and Sandhoff Diseases

AXO-AAV-GM2 is the first investigational gene therapy to receive IND clearance in Tay-Sachs and Sandhoff diseases Represents Axovant’s second IND clearance for a gene therapy program in the last 12 months NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Axovant …

Distribution channels: Media, Advertising & PR, Technology ...

Published on November 9, 2020 - 12:00 GMT

Great Elm Capital Corp. Declares Quarterly Cash Distribution of $0.10 per Share

WALTHAM, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (“we,” “us,” “our,” “GECC,” or “Great Elm BDC”), (NASDAQ: GECC), a business development company (BDC), today announced that Great Elm BDC’s Board set the distribution for the quarter …

Distribution channels: Banking, Finance & Investment Industry ...

Published on November 9, 2020 - 12:00 GMT

Applied Therapeutics Announces Presentation of Pre-Clinical Data on AT-001 for the Treatment of Diabetic Cardiomyopathy at the ...

NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on November 9, 2020 - 12:00 GMT

Recro Reports Third Quarter 2020 Financial Results

Company Secures Three-Year Renewal of License and Supply Agreement with Lannett, A Generics Pharmaceutical Company, for Manufacturing of Verelan PM®, Verelan SR® and Verapamil PM Strong Technical Performance Delivered Multiple New Contract Wins; Customers …

Distribution channels:

Published on November 9, 2020 - 12:00 GMT

Enthusiast Gaming Planning to List on NASDAQ

TORONTO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX: EGLX)(OTCQB: ENGMF)(FSE: 2AV), North America’s and the UK’s largest platform of communities for video game and esports fans is pleased …

Distribution channels: Consumer Goods, Media, Advertising & PR ...

Published on November 9, 2020 - 12:00 GMT

Microbot Medical to Highlight Progress and Recent Achievements at H.C. Wainwright 6th Annual Israel Conference

Webcast to be Held on Thursday November 12th at 2:00pm ET HINGHAM, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that Harel Gadot, the Company’s CEO, President and Chairman, will be providing an overview of the …

Distribution channels: